FDA approves Takeda's Entyvio for UC, Crohn's

FDA approved Entyvio vedolizumab from Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) to treat moderate to severe ulcerative colitis (UC) and moderate to severe Crohn's disease. Takeda could not be reache...